TGA
BCAX

TPG GP A’s Bicara Therapeutics BCAX Stock Holding History

TPG GP A’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.9M Hold
3,010,425
– – 1.63% 11
2025
Q4 		$50.7M Hold
3,010,425
– – 1.89% 7
2025
Q3 		$47.5M Hold
3,010,425
– – 2.59% 5
2025
Q2 		$28M Hold
3,010,425
– – 1.49% 7
2025
Q1 		$39.2M Hold
3,010,425
– – 0.79% 25
2024
Q4 		$52.4M Hold
3,010,425
– – 0.85% 24
2024
Q3 		$76.7M Buy
+3,010,425
New +$76.8M 1.31% 16

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM